Indraprastha Medical Corporation Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Indraprastha Medical Corporation Share Price

379.80-0.50 (-0.14%)

Closed
As On: 18 Jun, 2026, 03:57 PM IST
As On: 18 Jun, 2026, 03:46 PM IST

Sector: Hospitals & All...
Industry: Hospital

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	383.10
High	384.70
Low	377.80
Prev Close	380.30
Volume	1,54,998
VWAP(₹)	380.72

Key Metrics

PE Ratio(x)	18.96
EPS - TTM(₹)	20.03
MCap(₹ Cr.)	3,481.74
MCap Rank	22
PB Ratio(x)	4.71
Div Yield(%)	1.05
Face Value(₹)	10.00
52W High(₹)	640.85
52W Low(₹)	342.00
MCap/Sales	2.30
Beta(1 Month)	0.31
BV/Share(₹)	80.76

Indraprastha Med share price insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 19.4% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Indraprastha Med Share Price Update
Indraprastha Medical Corporation Ltd. share price moved down by -0.14% from its previous close of Rs 380.30. Indraprastha Medical Corporation Ltd. stock last traded price is 379.80
Share Price Value
Today/Current/Last 379.80380.95
Previous Day 380.30380.70

Found Insights useful?

Indraprastha Med Share Price Returns

1 Day	-0.14%
1 Month	5.47%
3 Months	-6.72%
1 Year	-4.9%
3 Years	318.51%
5 Years	333.56%

Indraprastha Med Share Recommendations

Mean recosCurrent

STRONG BUY

1 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	1	1	1	1
Buy	-	-	-	-
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	1	1	1	1

Recent Recos

Target₹83.25
OrganizationHDFC Securities
BUY

View all Stock Recommendations

News & Analysis

View all Indraprastha Med Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	378.76	388.40	371.96	340.10	330.06
Total Income Growth (%)	-2.48	4.42	9.37	3.04	-7.25
Total Expenses	320.91	320.58	302.09	283.34	283.95
Total Expenses Growth (%)	0.10	6.12	6.62	-0.21	-4.51
EBIT	57.85	67.82	69.87	56.76	46.11
EBIT Growth (%)	-14.70	-2.93	23.10	23.10	-21.21
Profit after Tax (PAT)	41.00	49.46	51.46	41.01	32.81
PAT Growth (%)	-17.10	-3.89	25.48	24.99	-22.62
EBIT Margin (%)	15.27	17.46	18.78	16.69	13.97
Net Profit Margin (%)	10.82	12.73	13.83	12.06	9.94
Basic EPS (₹)	4.47	5.40	5.61	4.47	3.58

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,379.01	1,261.59	1,108.70	891.28	614.06
Total Revenue Growth (%)	9.31	13.79	24.39	45.15	-26.15
Total Expenses	1,162.69	1,095.48	991.52	812.21	609.77
Total Expenses Growth (%)	6.14	10.48	22.08	33.20	-22.15
Profit after Tax (PAT)	160.99	123.96	86.15	58.62	2.33
PAT Growth (%)	29.87	43.89	46.96	2,416.96	-94.66
Operating Profit Margin (%)	16.41	13.67	11.05	9.28	1.24
Net Profit Margin (%)	11.86	9.95	7.84	6.60	0.37
Basic EPS (₹)	17.56	13.52	9.40	6.39	0.25

All figures in Rs Cr, unless mentioned otherwise

Insights

Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 19.4% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	851.62	723.24	555.14	461.71	431.96
Total Assets Growth (%)	17.75	30.28	20.24	6.89	-3.79
Total Liabilities	254.94	245.48	175.69	136.27	159.20
Total Liabilities Growth (%)	3.85	39.72	28.93	-14.40	-12.14
Total Equity	596.68	477.76	379.45	325.44	272.76
Total Equity Growth (%)	24.89	25.91	16.60	19.31	1.85
Current Ratio (x)	2.41	1.86	1.72	1.68	1.22
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	114.09	75.25	88.50	74.43	56.96

All figures in Rs Cr, unless mentioned otherwise

Insights

Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	156.75	200.15	144.47	71.29	27.90
Net Cash used in Investing Activities	-110.99	-158.43	-107.91	-51.10	-20.16
Net Cash flow from Financing Activities	-45.88	-32.38	-26.04	-3.37	-3.15
Net Cash Flow	-0.12	9.34	10.52	16.82	4.59
Closing Cash & Cash Equivalent	61.48	61.60	52.26	41.74	24.92
Closing Cash & Cash Equivalent Growth (%)	-0.19	17.87	25.20	67.49	22.57
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 177.61 cr for investing activities which is an YoY increase of 60.02%. (Source: Standalone Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	26.98	25.94	22.70	18.01	0.85
Return on Capital Employed (%)	33.07	30.50	28.54	22.40	2.41
Return on Assets (%)	18.90	17.13	15.51	12.69	0.53
Interest Coverage Ratio (x)	42.57	51.79	37.55	34.43	2.29
Asset Turnover Ratio (x)	1.72	1.95	2.16	1.99	142.00
Price to Earnings (x)	22.03	12.71	8.28	9.15	212.77
Price to Book (x)	5.93	3.30	1.88	1.65	1.81
EV/EBITDA (x)	12.05	6.42	3.63	3.98	11.36
EBITDA Margin (%)	19.67	16.89	14.62	13.22	6.67

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Indraprastha Med	18.96	4.70	24.80	30.66	18.52	10.76	17.00	12.38	20.03	2.46	0.00	0.00
Park Medi World Ltd.	43.46	5.24	12.76	18.10	9.17	10.27	24.62	16.28	6.87	2.06	0.11	0.69
Healthcare Global	666.06	6.51	1.03	8.48	0.35	14.45	9.68	0.83	0.97	1.12	0.68	2.62
Jupiter Life Line Hospitals	45.37	5.70	12.56	13.81	8.14	19.32	19.86	12.94	29.59	3.02	0.33	1.90
Yatharth Hospital	46.23	4.51	9.70	10.96	7.68	32.70	19.06	14.10	18.20	3.87	0.14	1.24
Add More

Annual Ratios (%)

Choose from Peers

Kovai Medical
Artemis Medicare
Dr. Agarwal's Eye Hospital
Shalby
Sakar Healthcare

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 4,67,53,000 51.00 % 0.00
Pledge 0 0.00 % 0.00
FII 22,33,151 2.43 % -0.28
DII 7,98,677 0.87 % 0.05
MF 7,787 0.01 % 0.01
Others 4,18,88,172 45.70 % 0.23
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 51.00 51.00 51.00 51.00
Pledge 0.00 0.00 0.00 0.00
FII 2.43 2.71 2.41 2.73
DII 0.87 0.82 3.51 3.56
Mutual Funds 0.01 0.00 2.62 2.62
Others 45.70 45.47 43.08 42.71

Mutual Funds Ownership

MF Ownership as on 31 May 2026

Groww BSE Hospitals ETF-G
Equity: Sectoral-Pharma
- 0.39
  Amount Invested (in Cr.)
- 0.77858031%
  % of AUM
- 36.18
  % Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma
- 0.05
  Amount Invested (in Cr.)
- 0.11%
  % of AUM
- -9.38
  % Change (MoM basis)
Bandhan BSE Healthcare Index Direct-G
Equity: Sectoral-Pharma
- 0.02
  Amount Invested (in Cr.)
- 0.11%
  % of AUM
- 6.69
  % Change (MoM basis)

View all Mutual Fund Schemes

Indraprastha Med Top Searches

Corporate Actions

Recent
Final
40%
May 12, 2026
Board Meeting
Audited Results & Final Dividend
May 04, 2026
General Meeting
-
Feb 18, 2026

Announced on	Meeting on
May 04, 2026	May 12, 2026
Audited Results & Final Dividend
Jan 19, 2026	Feb 03, 2026
Quarterly Results
Oct 17, 2025	Nov 01, 2025
Quarterly Results
Jul 22, 2025	Aug 06, 2025
Quarterly Results
May 05, 2025	May 16, 2025
Audited Results & Final Dividend

Dividends
Announced on Ex-Date Dividend%
May 16, 2025 Sep 18, 2025 45%
May 17, 2024 Sep 13, 2024 45%
May 23, 2023 Sep 15, 2023 30%
May 20, 2022 Sep 15, 2022 25%
May 12, 2026 - 40%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Feb 18, 2026	Mar 22, 2026
-
Aug 06, 2025	Sep 24, 2025
-
Aug 07, 2024	-
Book closure from Sep 14, 2024 to Sep 24, 2024
Aug 07, 2024	-
Book closure from Sep 14, 2024 to Sep 24, 2024
Aug 07, 2024	-
Book closure from Sep 14, 2024 to Sep 24, 2024

About Indraprastha Med

Indraprastha Medical Corporation Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 3,481.74 Crore) operating in Hospitals & Allied Services sector.

Indraprastha Medical Corporation Ltd. key Products/Revenue Segments include Hospital Services, Licence Fees, Miscellaneous Income and Other Operating Revenue for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Standalone Total Income of Rs 372.14 Crore, down 1.75 % from last quarter Total Income of Rs 378.76 Crore and up 9.42 % from last year same quarter Total Income of Rs 340.10 Crore. Company has reported net profit after tax of Rs 41.70 Crore in latest quarter.

The company’s top management includes Dr.Prathap C Reddy, Mr.Shivakumar Pattabhiraman, Ms.Madhumita Ganguli, Prof. (Dr)Mahesh Verma, Mr.Salil Singhal, Mr.Sandip Somany, Dr.(Ms.)Sangita Reddy, Mr.Sudhir Jalan, Dr.(Ms.)Suneeta Reddy, Mr.Tejpreet Singh Chopra, Mr.Vinayak Chatterjee, Ms.Vineeta Rai, Mr.Chander Prakash Tyagi, Mr.Priya Ranjan. Company has S N Dhawan & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 9.17 Crore shares outstanding.

Indraprastha Med Share Price Today is Rs. 379.80. On previous day, the Indraprastha Med Share Price (NSE) closed at Rs. 382.2, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 51.0% of the stake in Indraprastha Med shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Indraprastha Med stocks was 2.43% as compared to 2.72% in Dec 2025 with decrease of 0.29%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 0.87% as compared to 0.82% in Dec 2025 with increase of 0.05%. Out of the total DII holdings in Indraprastha Med shares 0.01% was held by mutual funds. The rest including public held is 45.7%. Indraprastha Med stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Indraprastha Med Dividend: Ever since 1988, Indraprastha Med dividends has been paid out around 26 times. As on 18 Jun, 2026, 03:57 PM IST, The overall dividend yield for Indraprastha Med stands at 1.05%. The last dividend paid was on September 18, 2025 (Rs. 4.5). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 20.03.

Indraprastha Med Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 372.14 Cr. of sales and 1.75% of quarterly net loss, there have been multiple ups and downs in the Indraprastha Med stock prices in the past few weeks. For example, Indraprastha Med stock price on 10th of June 2026 was around Rs. 380.8. Indraprastha Med share price now stands at an average of Rs. 379.80. Judging by last week's performance, stock is in up trend.

Indraprastha Med has a median target price of Rs. 550.0 in 12 months by 1 analysts. They have provided a high estimate of Rs. 550.0 and low estimate of Rs. 550.0 for Indraprastha Med share.

Historical Prices and Performance:
Indraprastha Med, incorporated in 1988 is a Small Cap company (with a market cap of Rs. 3486.32) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Indraprastha Med stock was 24.8%, 26.98%, 25.94%, 22.7% and 18.01% respectively.
The Indraprastha Med share gave a 3 year return of 319.06% as compared to Nifty 50 which gave a return of 27.94%.
Indraprastha Med announced 45.0% final dividend on September 18, 2025.

Key Metrics:
PE Ratio of Indraprastha Med is 19.08
Prices/Sales Ratio of Indraprastha Med is 2.3
Price/Book Ratio of Indraprastha Med is 4.73

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Indraprastha Med, major competitors and peers include Park Medi World Ltd., Healthcare Global, Jupiter Life Line Hospitals and Yatharth Hospital. As of Dec 2025, the dividend yield of Indraprastha Med stands at 1.05% while Park Medi World Ltd., Healthcare Global, Jupiter Life Line Hospitals and Yatharth Hospital stand at 0.0%, 0.0%, 0.07% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 19.08 and 4.73 respectively.

Leadership of Indraprastha Med :
Priya Ranjan is Asst. Vice President & Co. Secretary
Chander Prakash Tyagi is Chief Financial Officer
Prathap C Reddy is Vice Chairman
Shivakumar Pattabhiraman is Managing Director
Sudhir Jalan is Director
Mahesh Verma is Director
Salil Singhal is Director
Suneeta Reddy is Director
Vinayak Chatterjee is Director
Vineeta Rai is Director
Sandip Somany is Director
Tejpreet Singh Chopra is Director
Madhumita Ganguli is Director
Sangita Reddy is Director

Show More

Industry

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

Sarita Vihar,Delhi-Mathura Road,New Delhi, Delhi - 110076

Contact

imclshares@apollohospitals.com

http://www.apollohospitals.com

Executive Leadership

PC

Prathap C Reddy

Vice Chairman

SP

Shivakumar Pattabhiraman

Managing Director

MG

Madhumita Ganguli

Director

MV

Mahesh Verma

Director

Show More

Auditors

S N Dhawan & Co. LLP

FAQs about Indraprastha Med share

1. What's Indraprastha Med share price today and what are Indraprastha Med share returns ?
As on 18 Jun, 2026, 03:57 PM IST Indraprastha Med share price is down by 0.14% basis the previous closing price of Rs 380.3. Indraprastha Med share price is Rs 379.80. Return Performance of Indraprastha Med Shares:
- 1 Week: Indraprastha Med share price moved up by 0.80%
2. What is 52 week high/low of Indraprastha Med share price?
In last 52 weeks Indraprastha Med share had a high price of Rs 640.85 and low price of Rs 342.00
3. What are the returns for Indraprastha Med share?
Return Performance of Indraprastha Med Shares:
- 1 Week: Indraprastha Med share price moved up by 0.80%
4. What is the PE & PB ratio of Indraprastha Med?
The PE ratio of Indraprastha Med stands at 18.96, while the PB ratio is 4.7.
5. What's the market capitalization of Indraprastha Med?
Indraprastha Med share has a market capitalization of Rs 3,481.74 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 22.

Top Gainers

As on 03:59 PM | 18 Jun 2026

789.90

111.40 (16.42%)

1,186.40

143.16 (13.73%)

163.00

16.35 (11.15%)

271.95

23.03 (9.26%)

New India Assurance

178.67

13.21 (7.99%)

Top Losers

As on 03:59 PM | 18 Jun 2026

82.31

-7.76 (-8.62%)

84.62

-5.74 (-6.36%)

1,812.40

-102.70 (-5.37%)

535.00

-23.65 (-4.24%)

1,119.40

-45.70 (-3.93%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.